Titan Pharmaceuticals
TTNP
#10793
Rank
NZ$10.59 M
Marketcap
NZ$7.96
Share price
-3.76%
Change (1 day)
20.70%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): NZ-$7.22

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$7.58. In 2023 the company made an earnings per share (EPS) of NZ-$12.80 an increase over its 2022 EPS that were of NZ-$26.23.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.22
2023NZ-$12.80-51.22%
2022NZ-$26.23-15.61%
2021NZ-$31.09-81.37%
2020NZ-$166.84-77.52%
2019NZ-$742.31-56.32%
2018NZ-$1,699-59.51%
2017NZ-$4,198-371.81%
2016NZ$1,544-144.35%
2015NZ-$3,482300%
2014NZ-$870.47-121.54%
2013NZ$4,041-151.38%
2012NZ-$7,865-11.54%
2011NZ-$8,891188.89%
2010NZ-$3,078-10%
2009NZ-$3,420
2007NZ-$14,021-2.38%
2006NZ-$14,363-39.13%
2005NZ-$23,596-16.87%
2004NZ-$28,383-22.43%
2003NZ-$36,5914.9%
2002NZ-$34,88161.9%
2001NZ-$21,544-13.7%
2000NZ-$24,96465.01%
1999NZ-$15,129-35.87%
1998NZ-$23,592-1824.71%
1997NZ$1,368-102.4%
1996NZ-$57,109

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.09-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.12-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ-$6.99-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.59-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ-$0.41-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.36-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA